Logo image of LILAK

LIBERTY LATIN AMERIC-CL C (LILAK) Stock Fundamental Analysis

NASDAQ:LILAK - BMG9001E1286 - Common Stock

8.24 USD
-0.04 (-0.48%)
Last: 8/29/2025, 8:00:02 PM
8.24 USD
0 (0%)
After Hours: 8/29/2025, 8:00:02 PM
Fundamental Rating

3

Overall LILAK gets a fundamental rating of 3 out of 10. We evaluated LILAK against 36 industry peers in the Diversified Telecommunication Services industry. While LILAK is still in line with the averages on profitability rating, there are concerns on its financial health. LILAK has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

LILAK had negative earnings in the past year.
LILAK had a positive operating cash flow in the past year.
In the past 5 years LILAK always reported negative net income.
In the past 5 years LILAK always reported a positive cash flow from operatings.
LILAK Yearly Net Income VS EBIT VS OCF VS FCFLILAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

LILAK's Return On Assets of -9.82% is on the low side compared to the rest of the industry. LILAK is outperformed by 91.67% of its industry peers.
The Return On Equity of LILAK (-192.88%) is worse than 86.11% of its industry peers.
LILAK's Return On Invested Capital of 4.98% is fine compared to the rest of the industry. LILAK outperforms 66.67% of its industry peers.
LILAK had an Average Return On Invested Capital over the past 3 years of 4.30%. This is below the industry average of 7.35%.
The last Return On Invested Capital (4.98%) for LILAK is above the 3 year average (4.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.82%
ROE -192.88%
ROIC 4.98%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
LILAK Yearly ROA, ROE, ROICLILAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

With a decent Operating Margin value of 14.37%, LILAK is doing good in the industry, outperforming 63.89% of the companies in the same industry.
LILAK's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 78.03%, LILAK belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
LILAK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.37%
PM (TTM) N/A
GM 78.03%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
LILAK Yearly Profit, Operating, Gross MarginsLILAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LILAK is destroying value.
Compared to 1 year ago, LILAK has less shares outstanding
Compared to 5 years ago, LILAK has more shares outstanding
Compared to 1 year ago, LILAK has a worse debt to assets ratio.
LILAK Yearly Shares OutstandingLILAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
LILAK Yearly Total Debt VS Total AssetsLILAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.16, we must say that LILAK is in the distress zone and has some risk of bankruptcy.
LILAK has a worse Altman-Z score (0.16) than 75.00% of its industry peers.
LILAK has a debt to FCF ratio of 37.83. This is a negative value and a sign of low solvency as LILAK would need 37.83 years to pay back of all of its debts.
The Debt to FCF ratio of LILAK (37.83) is worse than 61.11% of its industry peers.
A Debt/Equity ratio of 12.50 is on the high side and indicates that LILAK has dependencies on debt financing.
LILAK's Debt to Equity ratio of 12.50 is on the low side compared to the rest of the industry. LILAK is outperformed by 86.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 12.5
Debt/FCF 37.83
Altman-Z 0.16
ROIC/WACC0.69
WACC7.21%
LILAK Yearly LT Debt VS Equity VS FCFLILAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

LILAK has a Current Ratio of 1.08. This is a normal value and indicates that LILAK is financially healthy and should not expect problems in meeting its short term obligations.
LILAK has a Current ratio of 1.08. This is comparable to the rest of the industry: LILAK outperforms 50.00% of its industry peers.
LILAK has a Quick Ratio of 1.08. This is a normal value and indicates that LILAK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.08, LILAK is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
LILAK Yearly Current Assets VS Current LiabilitesLILAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

LILAK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1346.34%.
The Revenue has decreased by -2.15% in the past year.
The Revenue has been growing slightly by 2.88% on average over the past years.
EPS 1Y (TTM)-1346.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-863.64%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-2.8%

3.2 Future

LILAK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.00% yearly.
Based on estimates for the next years, LILAK will show a small growth in Revenue. The Revenue will grow by 2.60% on average per year.
EPS Next Y82.44%
EPS Next 2Y44.84%
EPS Next 3Y30.42%
EPS Next 5Y27%
Revenue Next Year-1.16%
Revenue Next 2Y0.85%
Revenue Next 3Y1.98%
Revenue Next 5Y2.6%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LILAK Yearly Revenue VS EstimatesLILAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
LILAK Yearly EPS VS EstimatesLILAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 -3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 25.25, which means the current valuation is very expensive for LILAK.
LILAK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LILAK is cheaper than 61.11% of the companies in the same industry.
LILAK is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 25.25
LILAK Price Earnings VS Forward Price EarningsLILAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LILAK indicates a rather cheap valuation: LILAK is cheaper than 80.56% of the companies listed in the same industry.
77.78% of the companies in the same industry are more expensive than LILAK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.64
EV/EBITDA 5.94
LILAK Per share dataLILAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

LILAK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LILAK's earnings are expected to grow with 30.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.84%
EPS Next 3Y30.42%

0

5. Dividend

5.1 Amount

LILAK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (8/29/2025, 8:00:02 PM)

After market: 8.24 0 (0%)

8.24

-0.04 (-0.48%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners65.42%
Inst Owner Change-89.09%
Ins Owners11.61%
Ins Owner ChangeN/A
Market Cap1.65B
Analysts76
Price Target7.87 (-4.49%)
Short Float %12.48%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2677.51%
Min EPS beat(2)-4518.74%
Max EPS beat(2)-836.29%
EPS beat(4)0
Avg EPS beat(4)-4375.62%
Min EPS beat(4)-10589%
Max EPS beat(4)-836.29%
EPS beat(8)2
Avg EPS beat(8)-5900.02%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.76%
Min Revenue beat(2)-4.03%
Max Revenue beat(2)-3.49%
Revenue beat(4)0
Avg Revenue beat(4)-3.47%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.18%
Revenue beat(12)0
Avg Revenue beat(12)-3.31%
Revenue beat(16)1
Avg Revenue beat(16)-2.55%
PT rev (1m)0.41%
PT rev (3m)5.17%
EPS NQ rev (1m)1200%
EPS NQ rev (3m)156.8%
EPS NY rev (1m)-5.99%
EPS NY rev (3m)-165.38%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-2.79%
Revenue NY rev (1m)-0.66%
Revenue NY rev (3m)-2.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.25
P/S 0.37
P/FCF 7.64
P/OCF 2.22
P/B 2.71
P/tB N/A
EV/EBITDA 5.94
EPS(TTM)-5.93
EYN/A
EPS(NY)0.33
Fwd EY3.96%
FCF(TTM)1.08
FCFY13.08%
OCF(TTM)3.71
OCFY45%
SpS22.04
BVpS3.04
TBVpS-20.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.82%
ROE -192.88%
ROCE 6.3%
ROIC 4.98%
ROICexc 5.25%
ROICexgc 10.26%
OM 14.37%
PM (TTM) N/A
GM 78.03%
FCFM 4.89%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
ROICexc(3y)4.63%
ROICexc(5y)4.26%
ROICexgc(3y)9.72%
ROICexgc(5y)8.98%
ROCE(3y)5.45%
ROCE(5y)5.02%
ROICexcg growth 3Y-0.27%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-1.91%
ROICexc growth 5Y1.9%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 12.5
Debt/FCF 37.83
Debt/EBITDA 4.86
Cap/Depr 56.57%
Cap/Sales 11.93%
Interest Coverage 1.06
Cash Conversion 47.45%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 0.16
F-Score4
WACC7.21%
ROIC/WACC0.69
Cap/Depr(3y)62.1%
Cap/Depr(5y)64.9%
Cap/Sales(3y)12.93%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1346.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-863.64%
EPS Next Y82.44%
EPS Next 2Y44.84%
EPS Next 3Y30.42%
EPS Next 5Y27%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-2.8%
Revenue Next Year-1.16%
Revenue Next 2Y0.85%
Revenue Next 3Y1.98%
Revenue Next 5Y2.6%
EBIT growth 1Y20.02%
EBIT growth 3Y-9.58%
EBIT growth 5Y-1.84%
EBIT Next Year876.12%
EBIT Next 3Y118.64%
EBIT Next 5Y85.12%
FCF growth 1Y9.83%
FCF growth 3Y-8.29%
FCF growth 5Y-8.09%
OCF growth 1Y-8.37%
OCF growth 3Y-9.38%
OCF growth 5Y-3.81%